DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Research & Reports

Searching in Market Access (2688)

Philadelphia | Pennsylvania | 2019 | Market Overview (Event Driven)

Philadelphia | Pennsylvania | 2019 | Market Overview (Event Driven)

Thank you!

Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.

Independence Blue Cross has negotiated several multiyear contracts with Philadelphia's dominant health systems and specialty physician groups. IBC's partnership with the University of Pennsylvania Health System demonstrates the highest level of risk, putting even the system’s readmissions at risk. Meanwhile, Jefferson Health’s close relationship with Main Line Health is another driver of payment reform. While there is low consolidation in the health system sector, smaller hospitals are partnering with the biggest integrated deliery networks to offer local access to top-notch specialists (cardiology, orthopedics, and cancer). The market also takes on more clinical trials for rare diseases with the creation of a new consortium, an opening for orphan drugs. Risk-sharing will grow in 2019, although hospitals will feel pressure to consolidate to handle funding squeezes. IBC and Penn Medicine will emerge in the short-term as the most affordable option, but Jefferson Health will remain competitive.

  • Pub Date: February 2019

Purchase Report

Recent reports:
You may also be interested in: